Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 74
Filter
1.
Antioxidants (Basel) ; 12(5)2023 May 04.
Article in English | MEDLINE | ID: mdl-37237908

ABSTRACT

Cognitive decline frequently occurs with increasing age, but mechanisms contributing to age-associated cognitive decline (ACD) are not well understood and solutions are lacking. Understanding and reversing mechanisms contributing to ACD are important because increased age is identified as the single most important risk factor for dementia. We reported earlier that ACD in older humans is associated with glutathione (GSH) deficiency, oxidative stress (OxS), mitochondrial dysfunction, glucose dysmetabolism and inflammation, and that supplementing GlyNAC (glycine and N-acetylcysteine) improved these defects. To test whether these defects occur in the brain in association with ACD, and could be improved/reversed with GlyNAC supplementation, we studied young (20-week) and old (90-week) C57BL/6J mice. Old mice received either regular or GlyNAC supplemented diets for 8 weeks, while young mice received the regular diet. Cognition and brain outcomes (GSH, OxS, mitochondrial energetics, autophagy/mitophagy, glucose transporters, inflammation, genomic damage and neurotrophic factors) were measured. Compared to young mice, the old-control mice had significant cognitive impairment and multiple brain defects. GlyNAC supplementation improved/corrected the brain defects and reversed ACD. This study finds that naturally-occurring ACD is associated with multiple abnormalities in the brain, and provides proof-of-concept that GlyNAC supplementation corrects these defects and improves cognitive function in aging.

3.
J Gerontol A Biol Sci Med Sci ; 78(1): 75-89, 2023 01 26.
Article in English | MEDLINE | ID: mdl-35975308

ABSTRACT

BACKGROUND: Elevated oxidative stress (OxS), mitochondrial dysfunction, and hallmarks of aging are identified as key contributors to aging, but improving/reversing these defects in older adults (OA) is challenging. In prior studies, we identified that deficiency of the intracellular antioxidant glutathione (GSH) could play a role and reported that supplementing GlyNAC (combination of glycine and N-acetylcysteine [NAC]) in aged mice improved GSH deficiency, OxS, mitochondrial fatty-acid oxidation (MFO), and insulin resistance (IR). To test whether GlyNAC supplementation in OA could improve GSH deficiency, OxS, mitochondrial dysfunction, IR, physical function, and aging hallmarks, we conducted a placebo-controlled randomized clinical trial. METHODS: Twenty-four OA and 12 young adults (YA) were studied. OA was randomized to receive either GlyNAC (N = 12) or isonitrogenous alanine placebo (N = 12) for 16-weeks; YA (N = 12) received GlyNAC for 2-weeks. Participants were studied before, after 2-weeks, and after 16-weeks of supplementation to assess GSH concentrations, OxS, MFO, molecular regulators of energy metabolism, inflammation, endothelial function, IR, aging hallmarks, gait speed, muscle strength, 6-minute walk test, body composition, and blood pressure. RESULTS: Compared to YA, OA had GSH deficiency, OxS, mitochondrial dysfunction (with defective molecular regulation), inflammation, endothelial dysfunction, IR, multiple aging hallmarks, impaired physical function, increased waist circumference, and systolic blood pressure. GlyNAC (and not placebo) supplementation in OA improved/corrected these defects. CONCLUSION: GlyNAC supplementation in OA for 16-weeks was safe and well-tolerated. By combining the benefits of glycine, NAC and GSH, GlyNAC is an effective nutritional supplement that improves and reverses multiple age-associated abnormalities to promote health in aging humans. Clinical Trials Registration Number: NCT01870193.


Subject(s)
Acetylcysteine , Insulin Resistance , Humans , Mice , Animals , Aged , Acetylcysteine/pharmacology , Acetylcysteine/metabolism , Glycine/metabolism , Health Promotion , Oxidative Stress , Aging/physiology , Glutathione , Dietary Supplements , Insulin Resistance/physiology , Inflammation/drug therapy , Inflammation/metabolism , Mitochondria/metabolism
4.
Acute Med ; 22(4): 261-263, 2023.
Article in English | MEDLINE | ID: mdl-38284639

ABSTRACT

A 32-year-old lady with a history of bulimia nervosa was noted to have a raised adjusted calcium of 2.94mmol/L associated with high parathyroid hormone (PTH) 17.2pmol/L. On review, she had an apparent hypercalcaemia for at least three years, and also had a chronic, severe alkalosis with a bicarbonate up to 81.9mEQ/L. Ionised calcium during that time had actually been low, down to 1.03mmol/L. This case highlights the effects of alkalosis on calcium, as more albumin is available for binding to ionised calcium. This results in a low ionised calcium, which triggers PTH release and overall leads to raised adjusted calcium levels. Clinicians may misdiagnose a similar patient with primary hyperparathyroidism and treatment would cause worsening of true hypocalcaemia.


Subject(s)
Alkalosis , Hyperparathyroidism, Primary , Female , Humans , Adult , Calcium , Hyperparathyroidism, Primary/diagnosis , Parathyroid Hormone/metabolism
5.
Nutrients ; 14(5)2022 Mar 07.
Article in English | MEDLINE | ID: mdl-35268089

ABSTRACT

Determinants of length of life are not well understood, and therefore increasing lifespan is a challenge. Cardinal theories of aging suggest that oxidative stress (OxS) and mitochondrial dysfunction contribute to the aging process, but it is unclear if they could also impact lifespan. Glutathione (GSH), the most abundant intracellular antioxidant, protects cells from OxS and is necessary for maintaining mitochondrial health, but GSH levels decline with aging. Based on published human studies where we found that supplementing glycine and N-acetylcysteine (GlyNAC) improved/corrected GSH deficiency, OxS and mitochondrial dysfunction, we hypothesized that GlyNAC supplementation could increase longevity. We tested our hypothesis by evaluating the effect of supplementing GlyNAC vs. placebo in C57BL/6J mice on (a) length of life; and (b) age-associated GSH deficiency, OxS, mitochondrial dysfunction, abnormal mitophagy and nutrient-sensing, and genomic-damage in the heart, liver and kidneys. Results showed that mice receiving GlyNAC supplementation (1) lived 24% longer than control mice; (2) improved/corrected impaired GSH synthesis, GSH deficiency, OxS, mitochondrial dysfunction, abnormal mitophagy and nutrient-sensing, and genomic-damage. These studies provide proof-of-concept that GlyNAC supplementation can increase lifespan and improve multiple age-associated defects. GlyNAC could be a novel and simple nutritional supplement to improve lifespan and healthspan, and warrants additional investigation.


Subject(s)
Acetylcysteine , Mitophagy , Acetylcysteine/metabolism , Acetylcysteine/pharmacology , Animals , Dietary Supplements , Genomics , Glutathione/metabolism , Glycine/therapeutic use , Longevity , Mice , Mice, Inbred C57BL , Mitochondria/metabolism , Mitophagy/genetics , Nutrients , Oxidative Stress
6.
Healthcare (Basel) ; 10(3)2022 Feb 22.
Article in English | MEDLINE | ID: mdl-35326887

ABSTRACT

Diabetes is the leading global cause for blindness, kidney failure and amputations. Preventing these complications requires optimal glycemic control, and it is imperative that diabetic patients understand the fundamental concepts of diabetes care. Although patients attend formal diabetes education classes, many do not comprehend basic concepts of diabetes, and are often noncompliant with diet, exercise and medications. A novel approach termed 'analogy-based comprehensive diabetes education' (ABCDE) was developed to educate HIV-patients with diabetes about basic concepts of diabetes care. The object of this manuscript is to report the results of a retrospective chart review on the impact of ABCDE on glycemic outcomes in 24 patients who had failed usual care (including formal diabetes education, physician visits, and diabetic medications), and were non-adherent with diet and medications. They received only the ABCDE without any changes in pharmacotherapy. The impact on glycosylated hemoglobin (HbA1c) and fasting blood glucose (FBG) was assessed at subsequent visits. HbA1c was found to decline by 22% and 33% after 3 and 6 months, respectively, with corresponding declines in FBG by 53% and 59%, respectively. These results suggest that ABCDE in outpatient diabetes clinics could be effective in behavior modification toward improving glycemic control, and warrants additional investigation.

7.
Antioxidants (Basel) ; 11(1)2022 Jan 13.
Article in English | MEDLINE | ID: mdl-35052658

ABSTRACT

Patients with type 2 diabetes (T2D) are known to have mitochondrial dysfunction and increased insulin resistance (IR), but the underlying mechanisms are not well understood. We reported previously that (a) adequacy of the antioxidant glutathione (GSH) is necessary for optimal mitochondrial fatty-acid oxidation (MFO); (b) supplementing the GSH precursors glycine and N-acetylcysteine (GlyNAC) in mice corrected GSH deficiency, reversed impaired MFO, and lowered oxidative stress (OxS) and IR; and (c) supplementing GlyNAC in patients with T2D improved GSH synthesis and concentrations, and lowered OxS. However, the effect of GlyNAC on MFO, MGO (mitochondrial glucose oxidation), IR and plasma FFA (free-fatty acid) concentrations in humans with T2D remains unknown. This manuscript reports the effect of supplementing GlyNAC for 14-days on MFO, MGO, IR and FFA in 10 adults with T2D and 10 unsupplemented non-diabetic controls. Fasted T2D participants had 36% lower MFO (p < 0.001), 106% higher MGO (p < 0.01), 425% higher IR (p < 0.001) and 76% higher plasma FFA (p < 0.05). GlyNAC supplementation significantly improved fasted MFO by 30% (p < 0.001), lowered MGO by 47% (p < 0.01), decreased IR by 22% (p < 0.01) and lowered FFA by 25% (p < 0.01). These results provide proof-of-concept that GlyNAC supplementation could improve mitochondrial dysfunction and IR in patients with T2D, and warrant additional research.

8.
J Nutr ; 151(12): 3606-3616, 2021 12 03.
Article in English | MEDLINE | ID: mdl-34587244

ABSTRACT

Cellular increases in oxidative stress (OxS) and decline in mitochondrial function are identified as key defects in aging, but underlying mechanisms are poorly understood and interventions are lacking. Defects linked to OxS and impaired mitochondrial fuel oxidation, such as inflammation, insulin resistance, endothelial dysfunction, and aging hallmarks, are present in older humans and are associated with declining strength and cognition, as well as the development of sarcopenic obesity. Investigations on the origins of elevated OxS and mitochondrial dysfunction in older humans led to the discovery that deficiencies of the antioxidant tripeptide glutathione (GSH) and its precursor amino acids glycine and cysteine may be contributory. Supplementation with GlyNAC (combination of glycine and N-acetylcysteine as a cysteine precursor) was found to improve/correct cellular glycine, cysteine, and GSH deficiencies; lower OxS; and improve mitochondrial function, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, and multiple aging hallmarks; and improve muscle strength, exercise capacity, cognition, and body composition. This review discusses evidence from published rodent studies and human clinical trials to provide a detailed summary of available knowledge regarding the effects of GlyNAC supplementation on age-associated defects and aging hallmarks, as well as discussing why GlyNAC supplementation could be effective in promoting healthy aging. It is particularly exciting that GlyNAC supplementation appears to reverse multiple aging hallmarks, and if confirmed in a randomized clinical trial, it could introduce a transformative paradigm shift in aging and geriatrics. GlyNAC supplementation could be a novel nutritional approach to improve age-associated defects and promote healthy aging, and existing data strongly support the need for additional studies to explore the role and impact of GlyNAC supplementation in aging.


Subject(s)
Cognitive Dysfunction , Healthy Aging , Acetylcysteine , Aged , Animals , Body Composition , Cognitive Dysfunction/drug therapy , Cognitive Dysfunction/prevention & control , Dietary Supplements , Glutathione/metabolism , Humans , Inflammation/metabolism , Mice , Mitochondria/metabolism , Muscle Strength , Oxidative Stress , Randomized Controlled Trials as Topic
10.
Clin Transl Med ; 11(3): e372, 2021 03.
Article in English | MEDLINE | ID: mdl-33783984

ABSTRACT

BACKGROUND: Oxidative stress (OxS) and mitochondrial dysfunction are implicated as causative factors for aging. Older adults (OAs) have an increased prevalence of elevated OxS, impaired mitochondrial fuel-oxidation (MFO), elevated inflammation, endothelial dysfunction, insulin resistance, cognitive decline, muscle weakness, and sarcopenia, but contributing mechanisms are unknown, and interventions are limited/lacking. We previously reported that inducing deficiency of the antioxidant tripeptide glutathione (GSH) in young mice results in mitochondrial dysfunction, and that supplementing GlyNAC (combination of glycine and N-acetylcysteine [NAC]) in aged mice improves naturally-occurring GSH deficiency, mitochondrial impairment, OxS, and insulin resistance. This pilot trial in OA was conducted to test the effect of GlyNAC supplementation and withdrawal on intracellular GSH concentrations, OxS, MFO, inflammation, endothelial function, genotoxicity, muscle and glucose metabolism, body composition, strength, and cognition. METHODS: A 36-week open-label clinical trial was conducted in eight OAs and eight young adults (YAs). After all the participants underwent an initial (pre-supplementation) study, the YAs were released from the study. OAs were studied again after GlyNAC supplementation for 24 weeks, and GlyNAC withdrawal for 12 weeks. Measurements included red-blood cell (RBC) GSH, MFO; plasma biomarkers of OxS, inflammation, endothelial function, glucose, and insulin; gait-speed, grip-strength, 6-min walk test; cognitive tests; genomic-damage; glucose-production and muscle-protein breakdown rates; and body-composition. RESULTS: GlyNAC supplementation for 24 weeks in OA corrected RBC-GSH deficiency, OxS, and mitochondrial dysfunction; and improved inflammation, endothelial dysfunction, insulin-resistance, genomic-damage, cognition, strength, gait-speed, and exercise capacity; and lowered body-fat and waist-circumference. However, benefits declined after stopping GlyNAC supplementation for 12 weeks. CONCLUSIONS: GlyNAC supplementation for 24-weeks in OA was well tolerated and lowered OxS, corrected intracellular GSH deficiency and mitochondrial dysfunction, decreased inflammation, insulin-resistance and endothelial dysfunction, and genomic-damage, and improved strength, gait-speed, cognition, and body composition. Supplementing GlyNAC in aging humans could be a simple and viable method to promote health and warrants additional investigation.


Subject(s)
Acetylcysteine/pharmacology , Cognition/drug effects , Glutathione/drug effects , Glycine/pharmacology , Inflammation/drug therapy , Muscle Strength/drug effects , Oxidative Stress/drug effects , Acetylcysteine/administration & dosage , Adult , Age Factors , Aged , Aged, 80 and over , Aging , DNA Damage/drug effects , Dietary Supplements , Endothelium/drug effects , Female , Free Radical Scavengers/administration & dosage , Free Radical Scavengers/pharmacology , Geriatric Assessment , Glycine/administration & dosage , Glycine Agents/administration & dosage , Glycine Agents/pharmacology , Humans , Insulin Resistance , Male , Mitochondria/drug effects , Pilot Projects , Young Adult
11.
Antioxidants (Basel) ; 11(1)2021 Dec 27.
Article in English | MEDLINE | ID: mdl-35052554

ABSTRACT

Humanity is battling a respiratory pandemic pneumonia named COVID-19 which has resulted in millions of hospitalizations and deaths. COVID-19 exacerbations occur in waves that continually challenge healthcare systems globally. Therefore, there is an urgent need to understand all mechanisms by which COVID-19 results in health deterioration to facilitate the development of protective strategies. Oxidative stress (OxS) is a harmful condition caused by excess reactive-oxygen species (ROS) and is normally neutralized by antioxidants among which Glutathione (GSH) is the most abundant. GSH deficiency results in amplified OxS due to compromised antioxidant defenses. Because little is known about GSH or OxS in COVID-19 infection, we measured GSH, TBARS (a marker of OxS) and F2-isoprostane (marker of oxidant damage) concentrations in 60 adult patients hospitalized with COVID-19. Compared to uninfected controls, COVID-19 patients of all age groups had severe GSH deficiency, increased OxS and elevated oxidant damage which worsened with advancing age. These defects were also present in younger age groups, where they do not normally occur. Because GlyNAC (combination of glycine and N-acetylcysteine) supplementation has been shown in clinical trials to rapidly improve GSH deficiency, OxS and oxidant damage, GlyNAC supplementation has implications for combating these defects in COVID-19 infected patients and warrants urgent investigation.

12.
Biomedicines ; 8(10)2020 Sep 30.
Article in English | MEDLINE | ID: mdl-33007928

ABSTRACT

Background: Patients with HIV (PWH) develop geriatric comorbidities, including functional and cognitive decline at a younger age. However, contributing mechanisms are unclear and interventions are lacking. We hypothesized that deficiency of the antioxidant protein glutathione (GSH) contributes to multiple defects representing premature aging in PWH, and that these defects could be improved by supplementing the GSH precursors glycine and N-acetylcysteine (GlyNAC). Methods: We conducted an open label clinical trial where eight PWH and eight matched uninfected-controls were studied at baseline. PWH were studied again 12-weeks after receiving GlyNAC, and 8-weeks after stopping GlyNAC. Controls did not receive supplementation. Outcome measures included red-blood cell and muscle GSH concentrations, mitochondrial function, mitophagy and autophagy, oxidative stress, inflammation, endothelial function, genomic damage, insulin resistance, glucose production, muscle-protein breakdown rates, body composition, physical function and cognition. Results: PWH had significant defects in measured outcomes, which improved with GlyNAC supplementation. However, benefits receded after stopping GlyNAC. Conclusions: This open label trial finds that PWH have premature aging based on multiple biological and functional defects, and identifies novel mechanistic explanations for cognitive and physical decline. Nutritional supplementation with GlyNAC improves comorbidities suggestive of premature aging in PWH including functional and cognitive decline, and warrants additional investigation.

13.
J Gerontol A Biol Sci Med Sci ; 73(9): 1167-1177, 2018 08 10.
Article in English | MEDLINE | ID: mdl-29538624

ABSTRACT

Metabolic, inflammatory, and functional changes occur in cardiovascular aging which may stem from oxidative stress and be remediable with antioxidants. Glutathione, an intracellular antioxidant, declines with aging, and supplementation with glutathione precursors, N-acetyl cysteine (NAC) and glycine (Gly), increases tissue glutathione. Thirty-month old mice were fed diets supplemented with NAC or NAC+Gly and, after 7 weeks, cardiac function and molecular studies were performed. The NAC+Gly supplementation improved diastolic function, increasing peak early filling velocity, and reducing relaxation time, left atrial volume, and left ventricle end diastolic pressure. By contrast, cardiac function did not improve with NAC alone. Both diet supplementations decreased cardiac levels of inflammatory mediators; only NAC+Gly reduced leukocyte infiltration. Several mitochondrial genes reduced with aging were upregulated in hearts by NAC+Gly diet supplementation. These Krebs cycle and oxidative phosphorylation enzymes, suggesting improved mitochondrial function, and permeabilized cardiac fibers from NAC+Gly-fed mice produced ATP from carbohydrate and fatty acid sources, whereas fibers from control old mice were less able to utilize fatty acids. Our data indicate that NAC+Gly supplementation can improve diastolic function in the old mouse and may have potential to prevent important morbidities for older people.


Subject(s)
Acetylcysteine/metabolism , Aging/physiology , Cardiovascular Physiological Phenomena/drug effects , Diet Therapy/methods , Dietary Supplements , Glycine/metabolism , Animals , Antioxidants/metabolism , Cellular Senescence/physiology , Glutathione/metabolism , Inflammation/metabolism , Mice , Mitochondria/metabolism , Oxidative Stress
15.
Curr Atheroscler Rep ; 17(4): 493, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25702057
16.
Radiat Prot Dosimetry ; 164(3): 298-303, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25406363

ABSTRACT

The whole-body counting facility at the Indira Gandhi Centre for Atomic Research uses an in-house built Masonite cut-sheet phantom for the calibration of whole-body monitors. Recently, an Indian Adult BOMAB phantom was procured as an additional utility to augment the facility. The present study is to generate full-energy peak efficiencies (FEPE) of the shielded chair (SC) whole-body counting system using the new BOMAB phantom through Monte Carlo (MC) simulations. The values are compared with that of the Masonite phantom. First, the SC was modelled along with the Masonite phantom to estimate the FEPE values and Compton scattering factors (CSFs) for different energies. The simulated values were validated against the measurements using the Masonite cut-sheet phantom (Masonite phantom). The validated SC model was used along with the Indian adult BOMAB phantom to estimate the FEPEs and the CSFs. The simulated BOMAB phantom values were compared with the simulated Masonite phantom values. The maximum deviation for both the FEPEs and CSFs was ±10% validating the use of the Masonite phantom as a calibration tool representing an Indian adult.


Subject(s)
Calibration , Computer Simulation , Monte Carlo Method , Phantoms, Imaging , Radiation Monitoring/instrumentation , Whole-Body Counting/instrumentation , Adult , Humans , India , Models, Theoretical
17.
Rev Sci Instrum ; 85(8): 086111, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25173336

ABSTRACT

A recent expansion of cold and ultracold molecule applications has led to renewed focus on molecular species preparation under ultrahigh vacuum conditions. Meanwhile, molecular beams have been used to study gas phase chemical reactions for decades. In this paper, we describe an apparatus that uses pulsed molecular beam technology to achieve high local gas densities, leading to faster reaction rates with cold trapped ions. We characterize the beam's spatial profile using the trapped ions themselves. This apparatus could be used for preparation of molecular species by reactions requiring excitation of trapped ion precursors to states with short lifetimes or for obtaining a high reaction rate with minimal increase of background chamber pressure.

18.
J Clin Endocrinol Metab ; 99(1): 169-77, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24081740

ABSTRACT

BACKGROUND: HIV-infected patients are reported to have impaired oxidation of fatty acids despite increased availability, suggesting a mitochondrial defect. We investigated whether diminished levels of a key mitochondrial antioxidant, glutathione (GSH), was contributing to defective fatty acid oxidation in older HIV-infected patients, and if so, the metabolic mechanisms contributing to GSH deficiency in these patients. METHODS: In an open-label design, 8 older GSH-deficient HIV-infected males were studied before and after 14 days of oral supplementation with the GSH precursors cysteine and glycine. A combination of stable-isotope tracers, calorimetry, hyperinsulinemic-euglycemic clamp, and dynamometry were used to measure GSH synthesis, fasted and insulin-stimulated (fed) mitochondrial fuel oxidation, insulin sensitivity, body composition, anthropometry, forearm-muscle strength, and lipid profiles. RESULTS: Impaired synthesis contributed to GSH deficiency in the patients and was restored with cysteine plus glycine supplementation. GSH improvement was accompanied by marked improvements in fasted and fed mitochondrial fuel oxidation. Associated benefits included improvements in insulin sensitivity, body composition, anthropometry, muscle strength, and dyslipidemia. CONCLUSIONS: This work identifies 2 novel findings in older HIV-infected patients: 1) diminished synthesis due to decreased availability of cysteine and glycine contributes to GSH deficiency and can be rapidly corrected by dietary supplementation of these precursors and 2) correction of GSH deficiency is associated with improvement of mitochondrial fat and carbohydrate oxidation in both fasted and fed states and with improvements in insulin sensitivity, body composition, and muscle strength. The role of GSH on ameliorating metabolic complications in older HIV-infected patients warrants further investigation.


Subject(s)
Body Composition/drug effects , Cysteine/administration & dosage , Glutathione/metabolism , Glycine/administration & dosage , HIV Infections/metabolism , Insulin Resistance , Mitochondria/drug effects , Age Factors , Anti-HIV Agents/therapeutic use , Dietary Supplements , Glutathione/deficiency , HIV Infections/diet therapy , HIV Infections/drug therapy , HIV-1 , Humans , Insulin Resistance/physiology , Male , Middle Aged , Mitochondria/metabolism , Oxidation-Reduction/drug effects
20.
Radiat Prot Dosimetry ; 162(3): 260-7, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24300341

ABSTRACT

In vivo monitoring of actinides in occupational workers is done using Phoswich detector by measuring the low-energy X ray and gamma rays. Quantification of actinides like plutonium and americium in the lungs is extremely difficult due to higher background in the low-energy regions, which is from ambient background as well as from the subject. In the latter case, it is mainly due to the Compton scattering of body potassium, which varies person-to-person. Hence, an accurate prediction of subject-specific background counts in the lower-energy regions is an essential element in the in vivo measurement of plutonium and americium. Empirical equations are established for the prediction of background count rate in (239)Pu and (241)Am lower-energy regions, called 'target regions', as a function of count rate in the monitoring region (97-130 keV)/(40)K region in the high-energy spectrum, weight-to-height ratio of the subject (scattering parameter) and the gender.


Subject(s)
Actinoid Series Elements/analysis , Background Radiation , Lung/radiation effects , Occupational Exposure/analysis , Radiation Monitoring/instrumentation , Radiation Monitoring/methods , Adult , Body Mass Index , Female , Humans , Lung/chemistry , Male , Middle Aged , Scintillation Counting , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...